Tibra Equities Europe’s AbbVie ABBV Stock Holding History

Tibra Equities Europe’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-76,800	Closed	-$6.19M	–	230
2019 Q1	$6.19M	Buy	+76,800	New	+$6.28M	0.62%	31
2018 Q3	–	Sell	-185,197	Closed	-$17.2M	–	196
2018 Q2	$17.2M	Buy	+185,197	New	+$18.1M	2.57%	4

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Tibra Equities Europe's ABBV Position: Q2 2019 in Review

Tibra Equities Europe sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 76,800 shares — an estimated $6.19M sold.

Tibra Equities Europe first reported a position in ABBV in Q2 2018 and held it in 2 quarters. The position peaked at $17.2M in Q2 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Tibra Equities Europe reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
Tibra Equities Europe sold 76,800 AbbVie shares in Q2 2019, an estimated $6.19M.
Tibra Equities Europe first reported a position in AbbVie in Q2 2018 and held it in 2 quarters.
Tibra Equities Europe's AbbVie position peaked at $17.2M in Q2 2018.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.